Inovio Pharmaceuticals
INO
#9650
Rank
โ‚น11.10 B
Marketcap
โ‚น107.42
Share price
-3.89%
Change (1 day)
-49.37%
Change (1 year)

Earnings for Inovio Pharmaceuticals (INO)

Earnings in 2026 (TTM): -โ‚น7.53 Billion

According to Inovio Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -โ‚น8.7 Billion, an increase over its 2024 earnings that were of -โ‚น10.37 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Inovio Pharmaceuticals from 1999 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚น7.53 Billion-13.48%
2025 -โ‚น8.7 Billion-16.07%
2024 -โ‚น10.37 Billion-20.03%
2023 -โ‚น12.96 Billion-51.56%
2022 -โ‚น26.75 Billion-8.26%
2021 -โ‚น29.16 Billion95.4%
2020 -โ‚น14.93 Billion36.62%
2019 -โ‚น10.93 Billion20.19%
2018 -โ‚น9.09 Billion10.94%
2017 -โ‚น8.2 Billion9.59%
2016 -โ‚น7.48 Billion118.9%
2015 -โ‚น3.42 Billion-10.67%
2014 -โ‚น3.83 Billion83.32%
2013 -โ‚น2.09 Billion
2011 -โ‚น2.16 Billion15.64%
2010 -โ‚น1.86 Billion37.7%
2009 -โ‚น1.36 Billion2.19%
2008 -โ‚น1.33 Billion-14.09%
2007 -โ‚น1.54 Billion19.12%
2006 -โ‚น1.3 Billion9.62%
2005 -โ‚น1.18 Billion5.77%
2004 -โ‚น1.12 Billion73.08%
2003 -โ‚น0.65 Billion12.75%
2002 -โ‚น0.58 Billion
2000 -โ‚น0.87 Billion53.93%
1999 -โ‚น0.57 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚น2.536 T-31,942.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น1.502 T-18,958.82%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
โ‚น668.39 B-8,491.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
-โ‚น189.19 Billion 2,275.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น744.16 B-9,443.15%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚น763.46 B-9,685.55%๐Ÿ‡ฌ๐Ÿ‡ง UK
Cleveland BioLabs
CBLI
-โ‚น0.27 Billion-96.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
-โ‚น15.44 Billion 93.75%๐Ÿ‡บ๐Ÿ‡ธ USA